MIR-10B EXPRESSION IN PSORIATIC ARTHRITIS PATIENTS WITH DAPSA SCORE REMISSION OR LOW DISEASE ACTIVITY

被引：1
|
作者：
Koksal, S. S. [1 ]
Ozturk, Z. [1 ]
Alkurt, U. [1 ]
Karatas, D. [1 ]
EskIler, G. Guney [2 ]
Cokluk, E. [3 ]
Ozkan, A. Deveci [2 ]
Erkorkmaz, U. [4 ]
Gonullu, E. [1 ]
机构：
[1] Sakarya Univ, Dept Rheumatol, Fac Med, Sakarya, Turkiye
[2] Sakarya Univ, Dept Med Biol, Fac Med, Sakarya, Turkiye
[3] Sakarya Univ, Dept Med Biochem, Fac Med, Sakarya, Turkiye
[4] Sakarya Univ, Dept Med Biostat, Fac Med, Sakarya, Turkiye
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Psoriatic arthritis; miRNA; Biomarkers;
D O I：
10.1136/annrheumdis-2023-eular.5536
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB1143
引用
收藏
页码：1801 / 1802
页数：2
相关论文
共 50 条
  • [21] SECUKINUMAB PROVIDES SUSTAINED REMISSION AND LOW DISEASE ACTIVITY RELATED TO DISEASE ACTIVITY INDEX FOR PSORIATIC ARTHRITIS (DAPSA): 2 YEAR RESULTS FROM THE FUTURE 2 STUDY
    Smolen, J. S.
    McInnes, I. B.
    Kvien, T. K.
    Pricop, L.
    Fox, T.
    Rasouliyan, L.
    Jugl, S.
    Gaillez, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1323 - 1324
  • [22] The Assessment of Disease Activity in Psoriatic Arthritis: MDA, VLDA, DAPSA, or Something Else?
    Lubrano, Ennio
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (07) : 663 - 664
  • [23] DISEASE ACTIVITY IN PSORIATIC ARTHRITIS-ESR (DAPSA-ESR) MAY BE A VALID TOOL TO EVALUATE DISEASE ACTIVITY IN PATIENTS WITH PSORIATIC ARTHRITIS WHEN CRP IS NOT AVAILABLE
    Ale, A. L. Coronel
    Schneeberger, E. E.
    Cerda, O. L.
    Zaffarana, C. A.
    Fornaro, M.
    Landi, M.
    Citera, G.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S118 - S118
  • [24] APPLICATION OF DISEASE ACTIVITY INDEX FOR PSORIATIC ARTHRITIS (DAPSA) IN A COHORT OF PATIENTS FOLLOWED IN THE INSTITUTE OF RHEUMATOLOGY PRAGUE
    Stolfa, J.
    Sedova, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 813 - 813
  • [25] WHAT DOES WORSENING IN DAPSA DISEASE ACTIVITY CATEGORIES MEAN FOR PATIENTS WITH PSORIATIC ARTHRITIS? AN ANALYSIS OF 222 PATIENTS
    Sousa, M.
    Smolen, J. S.
    Gorlier, C.
    de Wit, M.
    Coates, L.
    Kalyoncu, U.
    Ruyssen-Witrand, A.
    Leung, K.
    Scrivo, R.
    Canete, J. D. D.
    Palominos, P.
    Meisalu, S.
    Balanescu, A.
    Kiltz, U.
    Aydin, S.
    Gaydukova, I.
    Dernis, E.
    Fautrel, B.
    Orbai, A. M.
    Lubrano, E.
    Gossec, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 214 - 215
  • [26] The Disease Activity Score in 28 joints in rheumatoid arthritis and psoriatic arthritis patients
    Leeb, Burkhard F.
    Andel, Ingrid
    Sautner, Judith
    Fassl, Christian
    Nothnagl, Thomas
    Rintelen, Bernhard
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2007, 57 (02): : 256 - 260
  • [27] Validation of the Disease Activity Index for Psoriatic Arthritis (DAPSA) with a Quick QuantitativeC-reactive Protein Assay (Q-DAPSA) in Patients with Psoriatic Arthritis (PsA): A Prospective,national, Multicenter Study
    Proft, Fabian
    Schally, Julia
    Brandt, Henning Christian
    Brandt-Jrgens, Jan
    Burmester, Gerd
    Haibel, Hildrun
    Kaeding, Henriette
    Karberg, Kirsten
    Lueders, Susanne
    Muche, Burkhard
    Protopopov, Mikhail
    Rademacher, Judith
    Rodriguez, Valeria Rios
    Torgutalp, Murat
    Verba, Maryna
    Zinke, Silke
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3737 - 3739
  • [28] ACHIEVEMENT OF PASDAS LOW DISEASE ACTIVITY AND VERY LOW DISEASE ACTIVITY IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH CERTOLIZUMAB PEGOL OVER 4 YEARS AND THE OVERLAP WITH DAPSA AND MDA DISEASE ACTIVITY TARGETS
    Coates, Laura C.
    Merola, Joseph F.
    Fitzgerald, Oliver
    Kavanaugh, Arthur
    Gottlieb, Alice B.
    Tillett, William
    Bauer, Lars
    Hoepken, Bengt
    Nurminen, Tommi
    Mease, Philip J.
    Helliwell, Philip
    van der Heijde, Desiree
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1836 - 1837
  • [29] Application of Treat to Target and Impact of Sustained Low Disease Activity or Remission on Function in Psoriatic Arthritis Patients
    Rahman, Proton
    Arendse, Regan
    Baer, Philip
    Zummer, Michel
    Rampakakis, Emmanouil
    Lehman, Allen
    Rachich, Meagan
    Nantel, Francois
    Asin-Milan, Odalis
    JOURNAL OF RHEUMATOLOGY, 2020, 47 (07) : 1103 - 1104
  • [30] APPLICATION OF TREAT TO TARGET AND IMPACT OF SUSTAINED LOW DISEASE ACTIVITY OR REMISSION ON FUNCTION IN PSORIATIC ARTHRITIS PATIENTS
    Rahman, Proton
    Arendse, Reagan
    Baer, Philip
    Zummer, Michael
    Rampakakis, Emmanouil
    Lehman, Allen J.
    Rachich, Meagan
    Nantel, Francois
    Asin-Milan, Odalis
    INTERNAL MEDICINE JOURNAL, 2020, 50 : 9 - 9
12345